Dr. Agarwal's Health Care Limited
NSE: AGARWALEYE · Hospital
Snapshot
Unlock Dr. Agarwal's Health Care Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Dr. Agarwal's Health Care Limited is an eye care provider operating a network of hospitals in India and internationally. The company offers a comprehensive range of ophthalmic services, including cataract, refractive, and retinal surgeries, alongside diagnostic consultations and the retail sale of optical and pharmaceutical products.
Business Model
The company generates revenue through a combination of surgical procedures, clinical consultations, diagnostic services, and the retail sale of eyewear and pharmaceutical products. Its model relies on a specialised hospital network providing both surgical and non-surgical eye care solutions.
Growth Outlook
Growth is driven by the expansion of its hospital network and the increasing demand for advanced ophthalmic procedures such as robotic cataract surgery and corneal transplantation. The company continues to scale its presence in both domestic and international markets to capture a larger share of the eye care sector.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent healthcare regulations and licensing requirements across its domestic and international operating regions.
- Medical Liability. As a healthcare provider, the company is exposed to potential litigation and reputational damage arising from medical errors or complications during surgical procedures.
- Competitive Pressure. The eye care market is highly fragmented, with significant competition from both large hospital chains and independent local practitioners.
- Technological Obsolescence. Rapid advancements in ophthalmic technology require continuous capital expenditure to maintain state-of-the-art surgical capabilities and remain competitive.
Start your research today
Unlock AI insights, financials, peers and live data on Dr. Agarwal's Health Care Limited and 5,000+ companies — free.
Key Metrics
P/E
109.6x
Q1 FY27 · consolidated
EV/EBITDA
25.2x
Q1 FY27 · consolidated
NET PROFIT MARGIN
9.0%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.1x
Q1 FY27 · consolidated
Peers · Hospital
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Dr. Agarwal's Health Care LimitedAGARWALEYE | ₹16,296 Cr | 109.62 | 25.19 | — | 29.4% | 9.5% | 10.8% | +23.8% |
Rainbow Childrens Medicare LtdRAINBOW | ₹14,698 Cr | 51.48 | 23.97 | 18.3% | 33.6% | 18.6% | 18.7% | -4.8% |
Park Medi WorldPARKHOSPS | ₹12,364 Cr | — | — | — | 27.0% | — | — | — |
Healthcare Global Enterprises Ltd.HCG | ₹10,454 Cr | 451.74 | 21.21 | 13.8% | 19.4% | 3.0% | 7.7% | +0.7% |
Yatharth Hospital & Trauma Care Services LimitedYATHARTH | ₹9,550 Cr | 52.72 | 28.25 | 44.0% | 25.4% | 10.2% | 12.7% | +28.9% |
Jupiter Life Line Hospitals Ltd.JLHL | ₹9,391 Cr | 10.01 | 25.62 | 18.2% | 24.7% | 12.8% | 14.6% | -80.1% |
As of Q1 FY27
Financials
Dr. Agarwal's Health Care Limited
NSE: AGARWALEYE · Hospital
Snapshot
Unlock Dr. Agarwal's Health Care Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Dr. Agarwal's Health Care Limited is an eye care provider operating a network of hospitals in India and internationally. The company offers a comprehensive range of ophthalmic services, including cataract, refractive, and retinal surgeries, alongside diagnostic consultations and the retail sale of optical and pharmaceutical products.
Business Model
The company generates revenue through a combination of surgical procedures, clinical consultations, diagnostic services, and the retail sale of eyewear and pharmaceutical products. Its model relies on a specialised hospital network providing both surgical and non-surgical eye care solutions.
Growth Outlook
Growth is driven by the expansion of its hospital network and the increasing demand for advanced ophthalmic procedures such as robotic cataract surgery and corneal transplantation. The company continues to scale its presence in both domestic and international markets to capture a larger share of the eye care sector.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent healthcare regulations and licensing requirements across its domestic and international operating regions.
- Medical Liability. As a healthcare provider, the company is exposed to potential litigation and reputational damage arising from medical errors or complications during surgical procedures.
- Competitive Pressure. The eye care market is highly fragmented, with significant competition from both large hospital chains and independent local practitioners.
- Technological Obsolescence. Rapid advancements in ophthalmic technology require continuous capital expenditure to maintain state-of-the-art surgical capabilities and remain competitive.
Start your research today
Unlock AI insights, financials, peers and live data on Dr. Agarwal's Health Care Limited and 5,000+ companies — free.
Key Metrics
P/E
109.6x
Q1 FY27 · consolidated
EV/EBITDA
25.2x
Q1 FY27 · consolidated
NET PROFIT MARGIN
9.0%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.1x
Q1 FY27 · consolidated
Peers · Hospital
As of Q1 FY27